1 Min Read
* ACASTI PHARMA REPORTS THIRD QUARTER FY 2018 FINANCIAL RESULTS
* ACASTI PHARMA INC - NET LOSS FOR QUARTER ENDED DECEMBER 31, 2017 WAS $0.40 PER SHARE Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.